XML 50 R31.htm IDEA: XBRL DOCUMENT v3.25.1

Accrued Expenses (Tables)

12 Months Ended

Dec. 31, 2024

Payables and Accruals [Abstract]

Schedule of Accrued Expenses

Accrued expenses consisted of the following at December 31:

 Schedule of Accrued Expenses

		2024				2023
Clinical trial costs		$	16,708,499			$	6,464,772
Accrued compensation			3,987,786				1,763,316
Other			1,384,803				641,512
Employee stock purchase plan			103,860				57,494
Total		$	22,184,948			$	8,927,094

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration